Results 301 to 310 of about 231,813 (388)

Ergothioneine Stimulates Ca²⁺-Mediated Brain-Derived Neurotrophic Factor Expression in NE-4C Nerve Cells. [PDF]

ACS Omega
Shi C, Asaba S, Nakamura S, Matsui T.
europepmc   +1 more source

Nerve Growth Factor and Brain-Derived Neurotrophic Factor in COVID-19. [PDF]

Biology (Basel)
Petrella C, Ferraguti G, Tarani L, Tarani F, Messina MP, Fiore M.   +5 more
europepmc   +1 more source

Neuroprotective effects of brain-derived neurotrophic factor in rodent and primate models of Alzheimer's disease

Nature Network Boston, 2009
A. Nagahara, D. Merrill, G. Coppola, Shingo Tsukada, B. E. Schroeder, G. Shaked, Ling Wang, A. Blesch, A. Kim, J. Conner, E. Rockenstein, M. Chao, E. Koo, D. Geschwind, E. Masliah, A. Chiba, M. Tuszynski   +16 more
semanticscholar   +1 more source

A narrative literature review about alpha‐lipoic acid role in dry eye and ocular surface disease

Acta Ophthalmologica, EarlyView.
Abstract Ocular surface diseases (OSD) include various conditions that affect the eye's surface, causing discomfort and pain. One such condition, dry eye disease (DED), is a multifactorial disorder that significantly impacts patients' quality of life, with prevalence rates ranging from 5% to 50% and higher incidence in women.
Antonio J. Mateo Orobia, José Manuel Benítez del Castillo, Margarita Calonge, Christophe Baudouin, Marc Labetoulle   +4 more
wiley   +1 more source

Brain-Derived Neurotrophic Factor (BDNF) as a Potential Biomarker in Brain Glioma: A Systematic Review and Meta-Analysis. [PDF]

Brain Behav
Hasani F, Masrour M, Khamaki S, Jazi K, Ghoodjani E, Teixeira AL.   +5 more
europepmc   +1 more source

Herpes simplex virus‐1 infection alters microtubule‐associated protein Tau splicing and promotes Tau pathology in neural models of Alzheimer's disease

Brain Pathology, EarlyView.
HSV‐1 infection alters MAPT splicing and promotes Tau pathology in neural models of Alzheimer's disease. HSV‐1 infection in brain organoids and neuronal models increase 4R‐MAPT splicing and Tau hyperphosphorylation. HSV‐1 ICP27 is both necessary and sufficient for inducing these changes highlighting the potential role of HSV‐1 in Alzheimer's disease ...
Emmanuel C. Ijezie, Michael J. Miller, Celine Hardy, Ava R. Jarvis, Timothy F. Czajka, Lianna D'Brant, Natasha Rugenstein, Adam Waickman, Eain Murphy, David C. Butler   +9 more
wiley   +1 more source

Relationship between serum mature brain-derived neurotrophic factor level and coronary slow flow phenomenon: a cross-sectional study. [PDF]

Sci Rep
Zhang H, Geater AF, Chongsuvivatwong V, Zhu G, Meng Y, Duan W, Pu L.   +6 more
europepmc   +1 more source

Preclinical models for evaluating psychedelics in the treatment of major depressive disorder

British Journal of Pharmacology, EarlyView.
Psychedelic drugs have seen a resurgence in interest as a next generation of psychiatric medicines with potential as rapid‐acting antidepressants (RAADs). Despite promising early clinical trials, the mechanisms which underlie the effects of psychedelics are poorly understood.
Laith Alexander, Dasha Anderson, Luke Baxter, Matthew Claydon, James Rucker, Emma S. J. Robinson   +5 more
wiley   +1 more source

Editorial Expression of Concern: The Possible Role of Brain-derived Neurotrophic Factor in Epilepsy. [PDF]

Neurochem Res
AlRuwaili R, Al-Kuraishy HM, Al-Gareeb AI, Ali NH, Alexiou A, Papadakis M, Saad HM, El-Saber Batiha G.   +7 more
europepmc   +1 more source

Psilocybin as a novel treatment for chronic pain

British Journal of Pharmacology, EarlyView.
Abstract Psychedelic drugs are under active consideration for clinical use and have generated significant interest for their potential as anti‐nociceptive treatments for chronic pain, and for addressing conditions like depression, frequently co‐morbid with pain.
Tate Askey, Reena Lasrado, Maria Maiarú, Gary J. Stephens   +3 more
wiley   +1 more source